Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
zainab_abdurrahman [2022/01/08 02:07] liam [Black Scientists’ Task Force on Vaccine Equity] | zainab_abdurrahman [2022/01/24 21:34] (current) liam [Zainab Abdurrahman] |
---|
====== Zainab Abdurrahman ====== | ====== Zainab Abdurrahman ====== |
| |
{{:drzainababdurrahman_cropped-180x180.jpeg?150 |}} | {{ :drzainababdurrahman_cropped-180x180.jpeg?150|}} |
| |
Dr. **Zainab Abdurrahman** is a member of the Drugs & Biologics Clinical Practice Guidelines Working Group of the [[Ontario COVID-19 Science Advisory Table]].((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved December 19, 2021, from https://covid19-sciencetable.ca/about/#abdurrahman-zainab)) | Dr. **Zainab Abdurrahman** is a member of the Drugs & Biologics Clinical Practice Guidelines Working Group of the [[Ontario COVID-19 Science Advisory Table]].((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved December 19, 2021, from https://covid19-sciencetable.ca/about/#abdurrahman-zainab)) |
Abdurrahman is Fellows in Training co-Supervisor for the [[Canadian Society of Allergy and Clinical Immunology]] (CSACI), from whom she receives funding for speakers bureau/honoraria and/or work on advisory boards.((Abdurrahman, Z. (2021, August 30). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Drugs-and-Biologics-Clinical-Practice-Guidelines-Working-Group_Zainab-Abdurrahman_20210830.pdf)) | Abdurrahman is Fellows in Training co-Supervisor for the [[Canadian Society of Allergy and Clinical Immunology]] (CSACI), from whom she receives funding for speakers bureau/honoraria and/or work on advisory boards.((Abdurrahman, Z. (2021, August 30). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Drugs-and-Biologics-Clinical-Practice-Guidelines-Working-Group_Zainab-Abdurrahman_20210830.pdf)) |
| |
| ==== Food Allergy Canada ==== |
| |
| Zainab has contributed to articles published by [[Food Allergy Canada]]((Abdurrahman, Z., & Upton, J. (2018, December 27). //Mythbuster: Someone who has been treated with an epinephrine auto-injector doesn’t necessarily need to go to the hospital.// Food Allergy Canada. https://foodallergycanada.ca/mythbuster-someone-who-has-been-treated-with-an-epinephrine-auto-injector-doesnt-necessarily-need-t o-go-to-the-hospital/)) ((//From the community.// (2016, November 10). Food Allergy Canada. https://archive.ph/wVYKu)) ((//Food Allergy Testing - What’s it All About?// (2016, January 3). Food Allergy Canada. https://foodallergycanada.ca/food-allergy-testing-whats-it-all-about/)) |
| |
| Food Allergy Canada received $50,000.00 CAD from the [[National Sciences and Engineering Research Council of Canada]] (NSERCC) for a Toronto, Ontario-based proposal titled "Encouraging vaccine confidence in Canadians at risk of anaphylaxis".((Natural Sciences and Engineering Research Council of Canada. (2021, July 26). //Encouraging vaccine confidence in Canada - Competition Results.// Natural Sciences and Engineering Research Council of Canada (NSERC). Retrieved November 3, 2021, from https://www.nserc-crsng.gc.ca/NSERC-CRSNG/FundingDecisions-DecisionsFinancement/2021/Vaccine_eng.asp#tphp)) |
| |
| Their corporate partners are [[pharmaceutical_companies:Bausch Health]], [[pharmaceutical_companies:Kaléo]], [[Nestlé]], [[PepsiCo]], [[pharmaceutical_companies:Pfizer]], [[Scotiabank]], [[sickkids|SickKids Foundation]], and [[TD Banking Group|TD Securities]].((//Who we work with.// Food Allergy Canada. Retrieved January 2, 2022, from https://foodallergycanada.ca/our-impact-advocacy-and-services/about-us/who-we-work-with/)) ((//Pivoting with the pandemic.// (2021). Food Allergy Canada. https://foodallergycanada.ca/wp-content/uploads/FAC-ImpactReport-2020.pdf)) |
==== McMaster University ==== | ==== McMaster University ==== |
| |